Cagrilintide acts through the amylin system agonism at amylin/calcitonin receptors a pathway entirely separate from the incretins
However, the Wellness Path isnt available as a standalone option at this time, and its unclear when it will return
It suggests that initiating treatment with GLP-1 agonists may be more effective than metformin in reducing dementia risk among individuals with type 2 diabetes
Much like any other disease state, if one type of therapy isnt feasible due to cost, access, tolerance, or just ineffectiveness for a specific patient, then pursuing an alternate treatment strategy is a very reasonable course of action, says Maselli
DOI: 10.2337/dc10-1006 Richie JP Jr, Nichenametla S, Neidig W, et al